AtriCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AtriCure and other ETFs, options, and stocks.

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. 

CEO
Michael H. Carrel
CEOMichael H. Carrel
Employees
1,350
Employees1,350
Headquarters
Mason, Ohio
HeadquartersMason, Ohio
Founded
1994
Founded1994
Employees
1,350
Employees1,350

ATRC Key Statistics

Market cap
1.61B
Market cap1.61B
Price-Earnings ratio
-329.43
Price-Earnings ratio-329.43
Dividend yield
Dividend yield
Average volume
1.38M
Average volume1.38M
High today
$31.82
High today$31.82
Low today
$29.96
Low today$29.96
Open price
$30.19
Open price$30.19
Volume
1.55M
Volume1.55M
52 Week high
$43.18
52 Week high$43.18
52 Week low
$25.36
52 Week low$25.36

Stock Snapshot

AtriCure(ATRC) stock is priced at $31.31, giving the company a market capitalization of 1.61B. It carries a P/E multiple of -329.43.

On 2026-07-03, AtriCure(ATRC) stock moved within a range of $29.96 to $31.82. With shares now at $31.31, the stock is trading +4.5% above its intraday low and -1.6% below the session's peak.

Trading volume for AtriCure(ATRC) stock has reached 1.55M, versus its average volume of 1.38M.

Over the past 52 weeks, AtriCure(ATRC) stock has traded between a high of $43.18 and a low of $25.36.

Over the past 52 weeks, AtriCure(ATRC) stock has traded between a high of $43.18 and a low of $25.36.

ATRC News

Investing.com 4d
Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com

...

Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com
Simply Wall St 4d
AtriCure Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving?

On 27 June 2026, AtriCure, Inc. (NasdaqGM: ATRC) was added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, enhancing its p...

AtriCure Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving?

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own ATRC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.